As we observe Veterans Day this month, it's critical to remember that military service is a key patient assessment point. The study analyzed how decision making and quality of life contribute to treatment regret in patients with prostate cancer. New research and therapeutic approaches are challenging long-held beliefs about this type of graft. As a nonpharmacological intervention with high acceptability and enjoyment, virtual reality may be an effective strategy. In addition to knowing what herbal products patients take, it’s equally as important to understand why they take them. Understanding critical symptoms in the “CRAB” acronym can enable oncology nurses to educate patients and caregivers. The FDA also approved the VENTANA CLDN18 RxDx Assay as a companion diagnostic device. Kohei Shitara, MD, unpacks the SPOTLIGHT and GLOW data behind the approval. Theresa Brown, RN, shares why it's critical for nurses to vote in the upcoming November election. The program, titled “Nurse Well-Being: Building Peer and Leadership Support,” is based on the Stress First Aid model. Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing. The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST. Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival. The first-of-its kind clinical trial was presented at the 2024 ASTRO Annual Meeting. Blood Cancer Awareness Month represents a critical opportunity to provide education on early signs and symptoms. Amy Pierre, RN, BSN, ANP-BC, shares what the annual observance means to her and the field as a whole. A long-term study points to the importance of evaluating risks and benefits with estrogen versus progesterone with estrogen. Theresa Brown, RN, weighs in on how structural racism has impacted the trajectory of the American health care system. Patients receiving the antibody-drug conjugate showed a 30% reduction in the risk of death compared with chemotherapy. A new study is shedding light on post-treatment experiences, with many saying they felt they were "left to themselves."